Questioning the safety of the COVID-19 vaccines was taboo just a short while ago. Now the Food and Drug Administration is restricting the use of one from a major drug company.
The FDA is limiting the use of the Johnson & Johnson vaccine due to the risk of blood clots, Breitbart reported. The product insert will now warn of potential “long-term and debilitating health consequences.”
Thursday’s ruling means J&J’s inoculation will only be recommended in narrow circumstances, such as for people who can’t take the other brands or who don’t have access to them. However, the FDA did not cancel the authorization altogether.
The federal agency still recommends the Moderna and Pfizer shots at this time. “If there’s an alternative that appears to be equally effective in preventing severe outcomes from COVID-19, we’d rather see people opting for that,” Dr. Peter Marks, vaccine chief at the FDA, said.
“But we’ve been careful to say that–compared to no vaccine–this is still a better option,” he added. Marks warned that the rare blood clots typically appear within the first two weeks after vaccination meaning those further out from their inoculation should be safe.
“So if you had the vaccine six months ago you can sleep soundly tonight knowing this isn’t an issue,” he said. Still, the fact that the FDA is now admitting the risk is notable.
Though relatively rare, the government was already aware of at least 60 cases of blood clots from J&J by late winter. Nine of those led to fatalities. The overall risk amounts to 3.23 incidents of blood clots per 1 million shots and women under 50 were most at risk, with one death per million.
The COVID-19 vaccines have been touted as safe and effective, but more information comes to light daily that they’re neither. Though this is a rare complication, it’s serious enough considering Americans were encouraged and even mandated to get these shots.